Robert Marsella serves as Executive at HOLLIS EDEN PHARMACEUTICALS INC /DE/, where they oversee executive responsibilities. Since joining the company, Robert Marsella has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 13, 2006 involved receiving (via award) 3,750 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 13, 2006 | HEPH | $0 | Award | 3,750 | $N/A | Discretionary |
Robert Marsella currently holds 17,407 shares of HOLLIS EDEN PHARMACEUTICALS INC /DE/ (HEPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Marsella has been a net neutral trader of HEPH stock. They have purchased $0 and sold $0 worth of shares.
Robert Marsella's most recent insider trade was on Feb 13, 2006, when they sold 3,750 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted